Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparative Study of MRI and Ultrasound for Detection of Primary Hepatocellular Carcinoma, Body Composition and Risk Factors for Decompensation in Liver Cirrhosis

NCT07291141 is registered in ClinicalTrials.gov with Mattias Ekstedt as lead sponsor.

NCT NCT07291141
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07291141 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparative Study of MRI and Ultrasound for Detection of Primary Hepatocellular Carcinoma, Body Composition and Risk Factors for Decompensation in Liver Cirrhosis
Lead sponsor
Mattias Ekstedt
Phase
Observational
Overall status
Recruiting
Start date
December 18, 2025
Completion date
December 31, 2031
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma (hcc), liver cirrhoses, mri, portal hypertension related to cirrhosis, sarcopenia in liver cirrhosis, ultrasound